Table 4. Clinicopathological characters.
Age, years | ||
<65 | 107 | |
≥65 | 134 | |
Gender | ||
Male | 144 | |
Female | 97 | |
Pathologic tumor status | ||
T1a/1b/1c | 1/0/17 | |
T2 | 133 | |
T3 | 90 | |
T4 | 0 | |
Pathologic node status | ||
N0 | 61 | |
N1 | 91 | |
N2 | 89 | |
Pathologic metastasis status | ||
M0 | 213 | |
M1 | 28 | |
Stage | ||
IA | 13 | |
IB | 34 | |
IIA | 14 | |
IIB | 89 | |
III | 63 | |
IV | 28 | |
Tumor grade | ||
Grade 1 | 32 | |
Grade 2 | 163 | |
Grade 3 | 46 | |
Nerve plexus invasiona | ||
Absence | 86 | |
Presence | 155 | |
Lymphatic invasiona | ||
0, 1 | 66 | |
2, 3 | 175 | |
Venous invasiona | ||
0, 1 | 62 | |
2, 3 | 179 | |
Intrapancreatic neural invasiona | ||
0, 1 | 80 | |
2, 3 | 161 | |
Tumor margin status | ||
Negative | 160 | |
Positive | 81 | |
Adjuvant chemotherapy | ||
Negative | 184 | |
Positive | 57 | |
Total | 241 |
aClassified according to the classification of pancreatic carcinoma of Japan Pancreas Society.